Exploring Ligand Stability in Protein Crystal Structures Using Binding Pose Metadynamics.

Area of Science:

• Computational chemistry
• Structural biology
• Drug discovery

Background:

• Accurate protein-ligand binding pose identification is critical for structure-based drug design and affinity evaluation.
• Crystallography provides static models, which may not fully represent dynamic binding interactions.
• Enhanced sampling methods are needed to assess ligand stability and conformational ensembles.

Purpose of the Study:

• To evaluate the robustness of Binding Pose Metadynamics (BPMD) for assessing protein-ligand binding pose accuracy.
• To determine if BPMD can distinguish between correctly and incorrectly modeled ligand poses in crystal structures.
• To validate BPMD using diverse crystal structures with varying ligand fits to electron density.

Main Methods:

• Utilized Binding Pose Metadynamics (BPMD), an enhanced sampling technique, to simulate ligand stability in solution.
• Applied BPMD to crystal structures with known incorrect ligand models.
• Tested BPMD on 63 diverse crystal structures from the Twilight database, assessing ligand fit to electron density.

Main Results:

• BPMD effectively assessed ligand stability in solution, reflecting occupancy in the energy landscape.
• The method successfully differentiated between protein-ligand binding poses supported by electron density and those that were not.
• Results demonstrated BPMD's capability in identifying incorrectly modeled ligand poses.

Conclusions:

• Binding Pose Metadynamics (BPMD) is a robust method for validating protein-ligand binding poses derived from experimental structures.
• BPMD provides a reliable assessment of ligand pose stability and its correlation with experimental electron density.
• This method can improve the accuracy of structure-based drug design by identifying unreliable binding poses.